Lung Cancer

Jul 01, 2020

Over the past few decades Cancer has emerged as a major public health concern worldwide. Cancer is the second leading cause of deaths that takes place worldwide. Every sixth death is due to cancer, and in 2018 was estimated to be responsible for 9.6 million deaths. Costing people quality of lives and eventually lea...

Jun 18, 2020

Lassen Therapeutics to create anti-IL-11 antibody for cancer and fibrosis Lassen Therapeutics is revealing USD 31 million from Frazier Healthcare Partners, Alta Venture and Longwood Fund and has an aim to create antibodies for cancer and fibrosis treatment. IL-11, a cytokine that plays a role in both disease are...

Jun 04, 2019

Sanofi’s Isatuximab combo extends lives in multiple myeloma Phase III trials of Sanofi’s investigational anti-CD38 monoclonal antibody, isatuximab combination therapy were successful in lowering down the multiple myeloma tumor rate in 60% of the patients in comparison to 35% reduction in the patients taking the...

May 31, 2019

WORLD NO TOBACCO DAY Every year, 31st May is observed as World Tobacco Day. This day is intended to spread awareness about health issues associated with tobacco use and to encourage the government to adopt effective policies to reduce the use of tobacco products. Every year, approximately 7 million people die du...

Nov 06, 2018

[caption id="attachment_3536" align="aligncenter" width="1360"] Lung Cancer Infographic[/caption] Lung cancer is among the leading cause of cancer deaths with the lowest survival rate. Early detection can increase the chances of survival. As November is #LungCancerAwareness Month, we are doing our part by increasin...

Sep 21, 2018

Cancer treatment methodologies are always evolving, and there cannot be any denying to the fact. In this uninterrupted pursuit, old formulas are sometimes used in new ways, arousing hopes for patients as well as commercial treatment providers. A case in point is the usage of light, which has long been used to see ca...

Aug 31, 2018

AbbVie Receives USFDA Approval for Imbruvica Plus Rituximab as First Chemotherapy-Free Combination Treatment for Waldenström's Macroglobulinemia Adults AbbVie announced that the USFDA approved Imbruvica (ibrutinib) plus rituximab (Rituxan) for the treatment of adult patients with Waldenström's macroglobulinemia (W...

May 02, 2017

FDA Approves Alunbrig (brigatinib) for Rare Lung Cancer Takeda Pharmaceuticals announced the FDA approved Alunbrig (brigatinib) to treat patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. Brigatinib is a kinas...

Nov 16, 2016

  A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical t...

Mar 03, 2015

Antibody–drug conjugates (ADCs), a new weapon of 21st Century for fighting Cancer Traditional cancer chemotherapy was having harsh side effects and also leads to systemic toxicity. The approach was also referred to as the carpet-bombing strategy for fighting cancer. Traditional chemotherapy does not discriminate b...